additional resources
ADDITIONAL RESOURCES
Cancer immunotherapy biomarker testing
Cancer immunotherapy biomarker testing – what pathologists need to know
 

Cancer immunotherapy has revolutionized the field of oncology. Based on a recently published article by Roche Tissue Diagnostics Chief Medical Officer Eric Walk, MD, "The Cancer Immunotherapy Biomarker Testing Landscape," this summary by the College of American Pathologists outlines those cancer immunotherapy biomarkers that are in routine use as a resource for individualized test selection in clinical pathology practice.

pd-l1-biomarker
10 reasons the PD-L1 biomarker is transforming tumor testing
 

When looking for ways to make more informed, data-driven decisions, companion diagnostics present a promising way forward for personalized healthcare. Here are 10 reasons the expanding application of this predictive assay is ideal for future-focused labs looking for a sustainable PD-L1 diagnostic solution.

whitepaper
White paper
 

U DISCOVERY 5-Plex IF procedure:  A fully automated immunofluorescence multiplex solution.

ihc-detection-guide
IHC detection guide for DISCOVERY platforms
 

Poster detailing IHC detection and amplification menu for DISCOVERY platforms.

discover-your-research-potential
Discover your research potential
 

Brochure on fully automated multiplex staining with DISCOVERY ULTRA staining system.